• Eastman Kodak reported first-quarter 2026 results on May 7, showing higher sales of US$229 million and revenue of US$265 million, but a wider net loss of US$16 million and basic loss per share of US$0.21 versus the prior year.
• Beneath the headline loss, performance in the Print and Advanced Materials & Chemicals segments supported growth in revenue, gross profit and Operational EBITDA, even as higher other charges and lower pension income weighed on bottom-line results.
• We’ll now explore what these mixed first-quarter results, particularly the stronger Print segment contribution, could mean for Eastman Kodak’s investment narrative.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is Eastman Kodak's Investment Narrative?

To own Eastman Kodak today, you really have to believe the company can turn its mix of legacy print, specialty film and newer advanced materials and pharma products into a consistently profitable business. The latest first quarter numbers fit that tension: better sales and revenue, stronger Print and Advanced Materials & Chemicals contributions, but still a wider net loss and losses per share. In the short term, catalysts still sit in execution on new offerings like VERITA 200D, scaling collaborations such as the Ateios RaiCore battery platform, and ramping the regulated pharma portfolio, rather than in any single quarter’s headline result. The Q1 loss keeps profitability risk front and center, and may sharpen investor focus on cash use, recent share price strength and whether higher-margin projects can support the current valuation.

However, one key risk is that continued losses could test confidence in Kodak’s recent share price gains. Eastman Kodak's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community span from just US$3.29 to a very large US$777.08, underscoring how far apart expectations sit. Set against Q1’s wider US$16.0 million loss and ongoing reliance on higher-margin Print and chemicals to lift results, that spread highlights why you may want to weigh several viewpoints before deciding how Kodak’s story fits your portfolio.

Explore 3 other fair value estimates on Eastman Kodak - why the stock might be worth less than half the current price!

Form Your Own Verdict

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Eastman Kodak research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free Eastman Kodak research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Eastman Kodak's overall financial health at a glance.

Interested In Other Possibilities?

Our top stock finds are flying under the radar-for now. Get in early:

• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
• This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.